Recent AUTL News
- Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 • GlobeNewswire Inc. • 10/28/2024 09:00:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/25/2024 08:01:19 PM
- Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress • GlobeNewswire Inc. • 10/16/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 11:00:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 12:09:53 PM
- Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:02:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 01:08:31 PM
- Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024 • GlobeNewswire Inc. • 08/27/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:21:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:27:52 PM
- Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
- Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 • GlobeNewswire Inc. • 07/26/2024 11:00:00 AM
- Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress • GlobeNewswire Inc. • 06/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:35:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:46 PM
- Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO • GlobeNewswire Inc. • 05/31/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/17/2024 08:39:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 12:27:03 PM
- Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 05/17/2024 11:00:00 AM
- Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress • GlobeNewswire Inc. • 05/14/2024 02:00:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/13/2024 01:33:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:23:04 AM
- Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call • GlobeNewswire Inc. • 05/13/2024 11:00:00 AM
- Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO • GlobeNewswire Inc. • 04/24/2024 02:00:00 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM